Facile Therapeutics

0 followers

‌

Facile Therapeutics is bringing Ebselen into the clinic to demonstrate it will be effective in preventing the recurrence of CDI in a Proof-of-Concept (PoC) clinical trial.

Industries

Headquarters

Employees

Links

Org chart

Marc Navre

Co-Founder, CEO & CSO

Marc Navre

Collapse

Allan Wagman

VP of CMC, Consulting Position

Teams

Advisory Roles

8 members

Leadership Team

3 members

Similar companies

Thermo Fisher Scientific

141 followers

Genentech

143 followers

Regeneron

87 followers

Alexion Pharmaceuticals

32 followers

Ionis Pharmaceuticals

22 followers

Exelixis

11 followers

Cytokinetics

11 followers

Avantor

10 followers

Charles River Laboratories

9 followers

Schrödinger

8 followers

REVOLUTION Medicines

5 followers

Discover companies